John Leyden

939 total citations
17 papers, 585 citations indexed

About

John Leyden is a scholar working on Oncology, Epidemiology and Neurology. According to data from OpenAlex, John Leyden has authored 17 papers receiving a total of 585 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 10 papers in Epidemiology and 8 papers in Neurology. Recurrent topics in John Leyden's work include Neuroendocrine Tumor Research Advances (10 papers), Lung Cancer Research Studies (10 papers) and Neuroblastoma Research and Treatments (8 papers). John Leyden is often cited by papers focused on Neuroendocrine Tumor Research Advances (10 papers), Lung Cancer Research Studies (10 papers) and Neuroblastoma Research and Treatments (8 papers). John Leyden collaborates with scholars based in Australia, New Zealand and United States. John Leyden's co-authors include Simon Harper, Philip B. Mitchell, Paul Glue, Verònica Gálvez, Colleen Loo, Andrew A. Somogyi, Rosalyn Lai, Teodora Kolarova, Richard R.P. Warner and Edward M. Wolin and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Journal of Affective Disorders.

In The Last Decade

John Leyden

16 papers receiving 577 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Leyden Australia 10 352 234 180 172 134 17 585
Christopher L. Sola United States 12 162 0.5× 116 0.5× 29 0.2× 18 0.1× 98 0.7× 23 619
A Garcia-Cebrian United Kingdom 6 205 0.6× 31 0.1× 13 0.1× 39 0.2× 116 0.9× 8 478
Jennifer L. Kruse United States 11 64 0.2× 213 0.9× 35 0.2× 20 0.1× 59 0.4× 21 423
Hiroshi Katagai Japan 13 169 0.5× 91 0.4× 10 0.1× 16 0.1× 31 0.2× 34 528
Trusharth Patel United States 5 98 0.3× 357 1.5× 12 0.1× 10 0.1× 19 0.1× 8 544
Ben H. Amit Israel 8 203 0.6× 133 0.6× 12 0.1× 9 0.1× 15 0.1× 15 329
Doron Mazeh Israel 16 89 0.3× 56 0.2× 18 0.1× 22 0.1× 17 0.1× 21 544
J. Wernicke United States 5 221 0.6× 30 0.1× 9 0.1× 14 0.1× 55 0.4× 10 424
Sophie Robert United States 11 111 0.3× 22 0.1× 66 0.4× 6 0.0× 43 0.3× 23 406
Maxime Barakat Canada 8 207 0.6× 109 0.5× 32 0.2× 3 0.0× 23 0.2× 19 455

Countries citing papers authored by John Leyden

Since Specialization
Citations

This map shows the geographic impact of John Leyden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Leyden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Leyden more than expected).

Fields of papers citing papers by John Leyden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Leyden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Leyden. The network helps show where John Leyden may publish in the future.

Co-authorship network of co-authors of John Leyden

This figure shows the co-authorship network connecting the top 25 collaborators of John Leyden. A scholar is included among the top collaborators of John Leyden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Leyden. John Leyden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
3.
4.
Hadži-Pavlović, Dušan, Stevan Nikolin, Michael Bull, et al.. (2019). The anaesthetic-ECT time interval with thiopentone—Impact on seizure quality. Journal of Affective Disorders. 252. 135–140. 9 indexed citations
5.
Wark, H., John Leyden, Dušan Hadži-Pavlović, et al.. (2019). Effects of the Anaesthetic-ECT time interval and ventilation rate on seizure quality in electroconvulsive therapy: A prospective randomised trial. Brain stimulation. 13(2). 450–456. 14 indexed citations
6.
Wolin, Edward M., et al.. (2017). Patient-Reported Experience of Diagnosis, Management, and Burden of Neuroendocrine Tumors. Pancreas. 46(5). 639–647. 44 indexed citations
7.
George, Duncan, Verònica Gálvez, Donel Martin, et al.. (2017). Pilot Randomized Controlled Trial of Titrated Subcutaneous Ketamine in Older Patients with Treatment-Resistant Depression. American Journal of Geriatric Psychiatry. 25(11). 1199–1209. 92 indexed citations
8.
Leyden, John, Nick Pavlakis, David Chan, et al.. (2017). Patient‐reported experience of the impact and burden of neuroendocrine tumors: Oceania patient results from a large global survey. Asia-Pacific Journal of Clinical Oncology. 14(3). 256–263. 9 indexed citations
9.
Leyden, John & Tsutomu Matsumoto. (2016). Gummi bears defeat fingerprint sensors.
10.
Singh, Simron, Donald Granberg, Edward M. Wolin, et al.. (2016). Patient-Reported Burden of a Neuroendocrine Tumor (NET) Diagnosis: Results From the First Global Survey of Patients With NETs. Journal of Global Oncology. 3(1). 43–53. 111 indexed citations
11.
Loo, Chu Kiong, Verònica Gálvez, E. O’Keefe, et al.. (2016). Placebo‐controlled pilot trial testing dose titration and intravenous, intramuscular and subcutaneous routes for ketamine in depression. Acta Psychiatrica Scandinavica. 134(1). 48–56. 171 indexed citations
12.
Gálvez, Verònica, Dušan Hadži-Pavlović, H. Wark, et al.. (2015). The Anaesthetic-ECT Time Interval in Electroconvulsive Therapy Practice – Is It Time to Time?. Brain stimulation. 9(1). 72–77. 34 indexed citations
13.
14.
15.
16.
Lai, Rosalyn, Natalie Katalinic, Paul Glue, et al.. (2014). Pilot dose–response trial of i.v. ketamine in treatment-resistant depression. The World Journal of Biological Psychiatry. 15(7). 579–584. 73 indexed citations
17.
Kolarova, Teodora, Maia Sissons, & John Leyden. (2014). Quantifying the Net Patient Experience Through the First Global Net Patient Survey: a Collaboration Between the International Neuroendocrine Cancer Alliance and Novartis. Annals of Oncology. 25. iv405–iv405. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christopher L. Sola Breakdown of academic impact, for papers by A Garcia-Cebrian Breakdown of academic impact, for papers by Jennifer L. Kruse Breakdown of academic impact, for papers by Hiroshi Katagai Breakdown of academic impact, for papers by Trusharth Patel Breakdown of academic impact, for papers by Ben H. Amit Breakdown of academic impact, for papers by Doron Mazeh Breakdown of academic impact, for papers by J. Wernicke Breakdown of academic impact, for papers by Sophie Robert Breakdown of academic impact, for papers by Maxime Barakat
Rankless by CCL
2026